Successful use of adalimumab in treating granuloma faciale resistant to traditional therapies
Australasian Journal of Dermatology · 2024
DOI: 10.1111/ajd.14260 ↗Kurz gefasst
Fallbericht in der Zeitschrift Australasian Journal of Dermatology, 2024. Verfasst von Martina Mussi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Adalimumab. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, Italy.
ORCID-Profile: Martina Mussi, Lidia Sacchelli
Zitieren
APA
Mussi, M., Zengarini, C., Viviani, F., Sacchelli, L., Pileri, A., & Bardazzi, F. (2024). Successful use of adalimumab in treating granuloma faciale resistant to traditional therapies. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14260
Vancouver
Mussi M, Zengarini C, Viviani F, Sacchelli L, Pileri A, Bardazzi F. Successful use of adalimumab in treating granuloma faciale resistant to traditional therapies. Australasian Journal of Dermatology. 2024. doi:10.1111/ajd.14260
BibTeX
@article{Mussi2024,
author = {Mussi, Martina and Zengarini, Corrado and Viviani, Filippo and Sacchelli, Lidia and Pileri, Alessandro and Bardazzi, Federico},
title = {Successful use of adalimumab in treating granuloma faciale resistant to traditional therapies},
journal = {Australasian Journal of Dermatology},
year = {2024},
doi = {10.1111/ajd.14260}
}
EUVIMED